Navigation Links
Register now for the European Congress on Osteoporosis & Osteoarthritis in Bordeaux
Date:12/6/2011

Don't miss out on low early bird rates for the premier bone meeting in 2012. The European Congress on Osteoporosis & Osteoarthritis (IOF-ECCEO12), from March 21-24, 2012 will be held in in the magnificent city of Bordeaux, France. Take advantage of low early bird rates: register by December 9, 2011 at http://www.iof-ecceo12.org

Enjoy a high quality programme led by international experts and key thought leaders...

Plenary lectures:

  • The conundrum of biological ageing - L. Partridge (Servier Honorary lecture)
  • Changes in epidemiology of osteoporotic fractures - C. Cooper
  • Gender specificity, the male paradigm - E. Orwoll
  • How bone is built - E. Seeman (Educational lecture)
  • Is Rheumatoid Arthritis a bone disease? - W.F. Lems
  • Current controversies in primary and secondary fracture prevention - E. McCloskey
  • How long should we treat - C. Roux
  • Risk-benefits of osteoporosis treatment: lessons from cohort or randomized controlled studies - B. Abrahamsen
  • FRAX: where are we now? - J. Kanis
  • Building new bone: is that possible? - S. Papapoulos

  • Meet-the-expert sessions:

  • Efficacy and safety of calcium supplements - S. Boonen
  • Management of osteoarthritis - T. Bardin
  • Sequential therapies - S. Ferrari
  • Sarcopenia and frailty: assessment and management (2 sessions) - A.A. Sayer & Y. Rolland
  • Clinical utility of bone turnover markers - J.C. Souberbielle
  • Avascular necrosis - T. Thomas
  • Obesity and fracture risk - J. Compston
  • Bone disease in primary hyperparathyroidism - J.P. Bilezikian
  • Nutrition and bone - B. Dawson-Hughes
  • Prevalent fracture and quality of life - J. Adachi
  • Whole body vibration - E. McCloskey and more...

  • Special symposia:

  • ESCEO-FIRMO Symposium - Prevention of bone fractures in post-menopausal women treated with aromatase inhibitors for breast cancer
  • ESCEO-FROMO-IOF Symposia
  • - Treatment of glucocorticod-induced osteoporosis (GIOP) - Treatment of osteoporosis in men - Tools to assess frailty and sarcopenia - Antidepressant medications and osteoporosis
  • ESCEO Symposium
  • - Diagnosis and treatment of osteoarthritis: state of the art
  • ESCEO-FROMO Symposium
  • - How to define responders in osteoarthritis?
  • GREES-ESCEO Symposium
  • - Health Claims for Nutriceuticals Products in the Field of Cartilage and Joint
  • ESCEO-ISPOR Symposium
  • - Compliance with osteoporosis medications: Causes of poor adherence; current statuts, clinical and economical consequences and interventions
  • GRIO-SFR Session
  • - Scientific Session jointly organized by the "Groupe de Recherche et d'Information sur les Ostoporoses" (GRIO) and the "Socit Franaise de Rhumatologie" (SFR)

    The program also includes seven informative Satellite Symposia, as well as oral and poster presentations. Several prestigious awards, including for young investigators, will be presented. Further information is available on the meeting website at http://www.iof-ecceo12.org

    Interested in translational bone research?
    The 2nd IOF-ESCEO Pre-Clinical Symposium, will be held from March 23-24, 2012 in conjunction with IOF-ECCEO12. This twoday forum dedicated to basic and translational bone research is free to registrants of IOF-ECCEO12 (or only 150 euro for access to Symposium alone). The Symposium is chaired by Stuart Ralston.

    Submit your abstract:
    Ensure your research is showcased at this internationally renowned congress. All abstracts will be published in 'Osteoporosis International'.
    Abstract Deadline: January 12, 2012

    Complete programme information is available at http://www.iof-ecceo12.org


    '/>"/>

    Contact: L. Misteli
    info@iofbonehealth.org
    International Osteoporosis Foundation
    Source:Eurekalert

    Related biology news :

    1. The Finnish Population Register Centre to Deploy Entrust EAC ePassport CA Solution
    2. Register now for the Society of Interventional Radiologys 34th Annual Scientific Meeting
    3. Last chance for media to pre-register for Europes largest cancer congress: ECCO15-ESMO34
    4. Register now online for the World Congress on Osteoporosis 2010 -- IOF WCO-ECCEO10
    5. Registered dietitians play essential role in management of gastric bypass patients
    6. Register now for the IOF Regionals -- 1st Asia-Pacific Osteoporosis Meeting
    7. Registered dietitians play essential role in effective management of diabetes in adults
    8. Researchers register new species using DNA-based description
    9. Maine registered dietitian sends an SOS to Senators Collins and Snowe
    10. Register now! Boston meeting will showcase latest aging discoveries
    11. IOF calls on European citizens to stand tall and speak out for their bones
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
    (Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
    (Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
    Breaking Biology News(10 mins):
    (Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
    (Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
    (Date:6/23/2016)... ... 23, 2016 , ... UAS LifeSciences, one of the leading ... UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing high ... its list of well-respected retailers. This list includes such fine stores as Whole ...
    (Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
    Breaking Biology Technology: